Telemonitoring App Study for Patients with Heart Failure
Tests a telemonitoring app that tracks health remotely in adults with heart failure.
Plain-language title generated from the registry record
Registry title: EVOLVING AZIMUTH IN MUSA CONTEXT
Key facts
- Where
- Milan, ItalySee the site
Where in Italy
- Fondazione IRCCS Cà Granda Ospedale Maggiore PoliclinicoMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Trial code
- NCT07022067
- Record updated
- 15 June 2025
- Original description
Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failureRead full original descriptionShow less
EVOLVING AZIMUTH IN MUSA CONTEXT
Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure
Inclusion: Have been diagnosed with chronic CS according to the ESC guidelines; Over 18 years of age; Patients admitted to hospital or with access to first aid within the last year; Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application); Wi-Fi or 3G coverage at home; Ability to give written informed consent.
Exclusion: Severe psychiatric disorder; Inability to use portable technologies; Patients unable to use the equipment provided; Patients who deny consent to study participation.